Research Square · Nov 20, 2026
Title: Outcomes of metabolic bariatric surgery in obese CKD patients: A MBSAQIP analysis
By Pena B, John A, Sanicola C et al.
Objective: Compare 30-day and 6-month postoperative outcomes after metabolic bariatric surgery in renal insufficiency (RI) and dialysis-dependent (DD) patients. Methods We conducted a retrospective cohort study using the 2023 MBSAQIP database, comparing bariatric surgery patients with RI, DD, and controls. Thirty-day and six-month outcomes included weight loss, complications, mortality, and obesity-related comorbidity changes. Multivariable logistic regression evaluated postoperative outcomes. Results Patients with RI and DD were older and had greater comorbidity burden than controls. At six months, > 10% total weight loss was achieved by 74% of RI, 80% of DD, and 85% of controls (p < 0.001), with improvement in diabetes and hypertension. Thirty-day mortality was < 0.2% and didn’t differ significantly between groups. At six months, mortality remained < 1%; however, RI and DD were independently associated with increased odds of mortality (OR 6.36 and 8.52), as well as any complications (OR 1.94 and 1.78), and readmission (OR 2.07 and 3.57, all p < 0.001), respectively, compared with controls. Conclusions Despite greater comorbidity burden, patients with RI and DD experienced low rates of major postoperative complications and mortality after bariatric surgery. Most achieved meaningful weight loss at six months, supporting bariatric surgery as an option for selected patients in advanced kidney disease.
doi.org/10.21203/rs.3.rs-11364442/v1Open accessInterventions